|
Market Closed -
Nasdaq
16:00:00 2026-10-22 EDT
|
5-day change | 1st Jan Change | ||
| 7.480 USD | -5.08% |
|
-12.62% | +23.03% |
| 09-20 | Exagen Inc.(NasdaqGM:XGN) dropped from S&P Global BMI Index | CI |
| 08-05 | B. Riley Adjusts Price Target on Exagen to $12 From $8, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EXAGEN INC. | Medical & Diagnostic Laboratories | -5.08% | -12.62% | +23.03% | -36.34% | -39.19% | 191M |  |  | |
- Stock Market
- Stocks
- XGN Stock
- Charts Exagen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
